0R15 7603.0 -1.7651% 0R1E 7406.0 -1.3848% 0M69 None None% 0R2V 168.75 -0.8811% 0QYR 1341.134 1.2177% 0QYP 392.5 -4.0342% 0LCV 132.52 -0.8084% 0RUK 2940.0 0.616% 0RYA 1742.0 -2.1348% 0RIH 157.95 -0.2211% 0RIH 155.51 -1.5448% 0R1O 171.25 9561.4951% 0R1O None None% 0QFP 8920.4336 76.9927% 0M2Z 296.7062 -0.5009% 0VSO 23.61 -33.6891% 0R1I None None% 0QZI 492.5 -0.1014% 0QZ0 220.0 0.0% 0NZF 859.0151 72.3546%
Stay apprised, Invest wise with KALKINE!
Health care stocks can be purely defensive play in an environment of rising interest rates and economic uncertainty.
The healthcare sector is currently expanding and offering long-term success stories given the innovations at hand, new approvals falling in place with relaxed norms and prevailing positive trends globally.
While the defensive and diverse nature of the sector governs the momentum, one also needs to look at the challenges that are mainly associated with the government regulatory changes, increased competition, safety concerns, outcome of research trials, and
The growth in aging population, people living longer with chronic disease, obesity and diabetes epidemics, technological advancements, the global reach of disease, personalized medicine, among others are the demand drivers.
Normal business environment after elevated demand induced by the Covid-19 pandemic can restrict the growth prospects. The sector can also be impacted by supply chain shortage, economic recession, fluctuating exchange rate movements, among others.
UK 
AU
CA
US
NZ
Please wait processing your request...